局部晚期宫颈癌术前新辅助化疗的近期治疗结局评价(4)
[8]Friedlander M L,Atkinson K,Coppleson J V,et al.The integration of chemotherapy into the management of locally advanced cervical cancer:a pilot study[J].Gynecol Oncol,1984,19(1):1-7.
[9]陈慧君,吴绪峰,梁川,等.新辅助化疗在局部晚期宫颈癌中的疗效观察[J].中国肿瘤临床,2007(04).
[10]郝敏,张娜.宫颈癌新辅助化疗与同步放化疗[J].中国实用妇科与产科杂志,2010(03).
[11]Mousavia A S,Vahidi S,Karimi-Zarchi M,et al.Response to neoadjuvant chemotherapy with paclitaxel and cisplatin in locally advanced cervical cancer[J].Eur J Gynaecol Oncol,2013,34(6):527-531.
[12]刘继红,熊樱.对宫颈癌新辅助化疗临床价值的评价[J].中国妇产科临床杂志,2008(03).
[13]黄清华,李力.宫颈癌新辅助化疗临床研究现状[J].国际妇产科学杂志,2009(05).
[14]Aoki Y,Tomita M,Sato T,et al.Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix[J].Gynecol Oncol,2001,83(2):263-267.
[15]Benedetti-Panici P,Greggi S,Colombo A,et al.Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer:results from the Italian multicenter randomized study[J].J Clin Oncol,2002,20(1):179-188.
[16]程曉东,吕卫国,叶枫,等.局部晚期子宫颈癌新辅助化疗价值的评估[J].中华妇产科杂志,2006(02).
[17]王光,黄玲惠,魏丽惠,等.宫颈癌新辅助化疗疗效分析[J].中国妇产科临床杂志,2013(01).
[18]Sardi J E,Giaroli A,Sananes C,et al.Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix:the final results[J].Gynecol Oncol,1997,67(1):61-69.
[19]Cai H B,Chen H Z,Yin H H.Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer[J].J Obstet Gynaecol Res,2006,32(3):315-323.
[20]Cormio G,Loizzi V,Carriero C,et al.Is there a role for neoadjuvant chemotherapy in early invasive cervical carcinoma[J].Eur J Gynaecol Oncol,2009,30(3):249-254.
编辑/成森, 百拇医药(曹雪 廖加群 鲁亮)
[9]陈慧君,吴绪峰,梁川,等.新辅助化疗在局部晚期宫颈癌中的疗效观察[J].中国肿瘤临床,2007(04).
[10]郝敏,张娜.宫颈癌新辅助化疗与同步放化疗[J].中国实用妇科与产科杂志,2010(03).
[11]Mousavia A S,Vahidi S,Karimi-Zarchi M,et al.Response to neoadjuvant chemotherapy with paclitaxel and cisplatin in locally advanced cervical cancer[J].Eur J Gynaecol Oncol,2013,34(6):527-531.
[12]刘继红,熊樱.对宫颈癌新辅助化疗临床价值的评价[J].中国妇产科临床杂志,2008(03).
[13]黄清华,李力.宫颈癌新辅助化疗临床研究现状[J].国际妇产科学杂志,2009(05).
[14]Aoki Y,Tomita M,Sato T,et al.Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix[J].Gynecol Oncol,2001,83(2):263-267.
[15]Benedetti-Panici P,Greggi S,Colombo A,et al.Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer:results from the Italian multicenter randomized study[J].J Clin Oncol,2002,20(1):179-188.
[16]程曉东,吕卫国,叶枫,等.局部晚期子宫颈癌新辅助化疗价值的评估[J].中华妇产科杂志,2006(02).
[17]王光,黄玲惠,魏丽惠,等.宫颈癌新辅助化疗疗效分析[J].中国妇产科临床杂志,2013(01).
[18]Sardi J E,Giaroli A,Sananes C,et al.Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix:the final results[J].Gynecol Oncol,1997,67(1):61-69.
[19]Cai H B,Chen H Z,Yin H H.Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer[J].J Obstet Gynaecol Res,2006,32(3):315-323.
[20]Cormio G,Loizzi V,Carriero C,et al.Is there a role for neoadjuvant chemotherapy in early invasive cervical carcinoma[J].Eur J Gynaecol Oncol,2009,30(3):249-254.
编辑/成森, 百拇医药(曹雪 廖加群 鲁亮)
参见:首页 > 医疗版 > 疾病专题 > 妇产科 > 女性生殖器官肿瘤及肿瘤样病变 > 子宫颈癌